 | • レポートコード：MRC2312MG08452 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のRNA治療学市場規模と予測を収録しています。・世界のRNA治療学市場：売上、2018年-2023年、2024年-2029年 ・世界のRNA治療学市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のRNA治療学市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「mRNA」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 RNA治療学のグローバル主要企業は、Moderna、 Alnylam Pharmaceuticals、 Novartis、 Ionis Pharmaceuticals、 Sarepta Therapeutics、 Sanofi、 Pfizer、 Arrowhead Pharmaceuticals、 BioNTech、 Orna Therapeutics、 CRISPR Therapeutics、 Silence Therapeutics、 Astellas Pharma Inc.、 CureVac、 Sirnaomics、 Arcturus Therapeutics、 Arbutus Biopharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、RNA治療学のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のRNA治療学市場：タイプ別、2018年-2023年、2024年-2029年 世界のRNA治療学市場：タイプ別市場シェア、2022年 ・mRNA、RNA干渉（RNAi）、アンチセンスオリゴヌクレオチド（ASO）、その他 世界のRNA治療学市場：用途別、2018年-2023年、2024年-2029年 世界のRNA治療学市場：用途別市場シェア、2022年 ・病院、研究機関 世界のRNA治療学市場：地域・国別、2018年-2023年、2024年-2029年 世界のRNA治療学市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるRNA治療学のグローバル売上、2018年-2023年 ・主要企業におけるRNA治療学のグローバル売上シェア、2022年 ・主要企業におけるRNA治療学のグローバル販売量、2018年-2023年 ・主要企業におけるRNA治療学のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Moderna、 Alnylam Pharmaceuticals、 Novartis、 Ionis Pharmaceuticals、 Sarepta Therapeutics、 Sanofi、 Pfizer、 Arrowhead Pharmaceuticals、 BioNTech、 Orna Therapeutics、 CRISPR Therapeutics、 Silence Therapeutics、 Astellas Pharma Inc.、 CureVac、 Sirnaomics、 Arcturus Therapeutics、 Arbutus Biopharma ************************************************************* ・調査・分析レポートの概要 RNA治療学市場の定義 市場セグメント 世界のRNA治療学市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のRNA治療学市場規模 世界のRNA治療学市場規模：2022年 VS 2029年 世界のRNA治療学市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのRNA治療学の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のRNA治療学製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：mRNA、RNA干渉（RNAi）、アンチセンスオリゴヌクレオチド（ASO）、その他 RNA治療学のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、研究機関 RNA治療学の用途別グローバル売上・予測 ・地域別市場分析 地域別RNA治療学市場規模 2022年と2029年 地域別RNA治療学売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Moderna、 Alnylam Pharmaceuticals、 Novartis、 Ionis Pharmaceuticals、 Sarepta Therapeutics、 Sanofi、 Pfizer、 Arrowhead Pharmaceuticals、 BioNTech、 Orna Therapeutics、 CRISPR Therapeutics、 Silence Therapeutics、 Astellas Pharma Inc.、 CureVac、 Sirnaomics、 Arcturus Therapeutics、 Arbutus Biopharma ... |
This research report provides a comprehensive analysis of the RNA Therapeutics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global RNA Therapeutics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of RNA Therapeutics, challenges faced by the industry, and potential opportunities for market players.
The global RNA Therapeutics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The RNA Therapeutics market presents opportunities for various stakeholders, including Hospitals, Research Institutions. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in RNA Therapeutics market. Additionally, the growing consumer demand present avenues for market expansion.
The global RNA Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the RNA Therapeutics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the RNA Therapeutics market.
Market Overview: The report provides a comprehensive overview of the RNA Therapeutics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., mRNA, RNA Interference (RNAi)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the RNA Therapeutics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the RNA Therapeutics market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the RNA Therapeutics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the RNA Therapeutics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the RNA Therapeutics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the RNA Therapeutics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for RNA Therapeutics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the RNA Therapeutics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
RNA Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
mRNA
RNA Interference (RNAi)
Antisense Oligonucleotide (ASO)
Other
Market segment by Application
Hospitals
Research Institutions
Global RNA Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Moderna
Alnylam Pharmaceuticals
Novartis
Ionis Pharmaceuticals
Sarepta Therapeutics
Sanofi
Pfizer
Arrowhead Pharmaceuticals
BioNTech
Orna Therapeutics
CRISPR Therapeutics
Silence Therapeutics
Astellas Pharma Inc.
CureVac
Sirnaomics
Arcturus Therapeutics
Arbutus Biopharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA Therapeutics, market overview.
Chapter 2: Global RNA Therapeutics market size in revenue.
Chapter 3: Detailed analysis of RNA Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 RNA Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA Therapeutics Overall Market Size
2.1 Global RNA Therapeutics Market Size: 2022 VS 2029
2.2 Global RNA Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA Therapeutics Players in Global Market
3.2 Top Global RNA Therapeutics Companies Ranked by Revenue
3.3 Global RNA Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 RNA Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies RNA Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 RNA Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global RNA Therapeutics Market Size Markets, 2022 & 2029
4.1.2 mRNA
4.1.3 RNA Interference (RNAi)
4.1.4 Antisense Oligonucleotide (ASO)
4.1.5 Other
4.2 By Type – Global RNA Therapeutics Revenue & Forecasts
4.2.1 By Type – Global RNA Therapeutics Revenue, 2018-2023
4.2.2 By Type – Global RNA Therapeutics Revenue, 2024-2029
4.2.3 By Type – Global RNA Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global RNA Therapeutics Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Research Institutions
5.2 By Application – Global RNA Therapeutics Revenue & Forecasts
5.2.1 By Application – Global RNA Therapeutics Revenue, 2018-2023
5.2.2 By Application – Global RNA Therapeutics Revenue, 2024-2029
5.2.3 By Application – Global RNA Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global RNA Therapeutics Market Size, 2022 & 2029
6.2 By Region – Global RNA Therapeutics Revenue & Forecasts
6.2.1 By Region – Global RNA Therapeutics Revenue, 2018-2023
6.2.2 By Region – Global RNA Therapeutics Revenue, 2024-2029
6.2.3 By Region – Global RNA Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America RNA Therapeutics Revenue, 2018-2029
6.3.2 US RNA Therapeutics Market Size, 2018-2029
6.3.3 Canada RNA Therapeutics Market Size, 2018-2029
6.3.4 Mexico RNA Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe RNA Therapeutics Revenue, 2018-2029
6.4.2 Germany RNA Therapeutics Market Size, 2018-2029
6.4.3 France RNA Therapeutics Market Size, 2018-2029
6.4.4 U.K. RNA Therapeutics Market Size, 2018-2029
6.4.5 Italy RNA Therapeutics Market Size, 2018-2029
6.4.6 Russia RNA Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries RNA Therapeutics Market Size, 2018-2029
6.4.8 Benelux RNA Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia RNA Therapeutics Revenue, 2018-2029
6.5.2 China RNA Therapeutics Market Size, 2018-2029
6.5.3 Japan RNA Therapeutics Market Size, 2018-2029
6.5.4 South Korea RNA Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia RNA Therapeutics Market Size, 2018-2029
6.5.6 India RNA Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America RNA Therapeutics Revenue, 2018-2029
6.6.2 Brazil RNA Therapeutics Market Size, 2018-2029
6.6.3 Argentina RNA Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa RNA Therapeutics Revenue, 2018-2029
6.7.2 Turkey RNA Therapeutics Market Size, 2018-2029
6.7.3 Israel RNA Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia RNA Therapeutics Market Size, 2018-2029
6.7.5 UAE RNA Therapeutics Market Size, 2018-2029
7 RNA Therapeutics Companies Profiles
7.1 Moderna
7.1.1 Moderna Company Summary
7.1.2 Moderna Business Overview
7.1.3 Moderna RNA Therapeutics Major Product Offerings
7.1.4 Moderna RNA Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Moderna Key News & Latest Developments
7.2 Alnylam Pharmaceuticals
7.2.1 Alnylam Pharmaceuticals Company Summary
7.2.2 Alnylam Pharmaceuticals Business Overview
7.2.3 Alnylam Pharmaceuticals RNA Therapeutics Major Product Offerings
7.2.4 Alnylam Pharmaceuticals RNA Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis RNA Therapeutics Major Product Offerings
7.3.4 Novartis RNA Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Company Summary
7.4.2 Ionis Pharmaceuticals Business Overview
7.4.3 Ionis Pharmaceuticals RNA Therapeutics Major Product Offerings
7.4.4 Ionis Pharmaceuticals RNA Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Ionis Pharmaceuticals Key News & Latest Developments
7.5 Sarepta Therapeutics
7.5.1 Sarepta Therapeutics Company Summary
7.5.2 Sarepta Therapeutics Business Overview
7.5.3 Sarepta Therapeutics RNA Therapeutics Major Product Offerings
7.5.4 Sarepta Therapeutics RNA Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Sarepta Therapeutics Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Company Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi RNA Therapeutics Major Product Offerings
7.6.4 Sanofi RNA Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Sanofi Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer RNA Therapeutics Major Product Offerings
7.7.4 Pfizer RNA Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Arrowhead Pharmaceuticals
7.8.1 Arrowhead Pharmaceuticals Company Summary
7.8.2 Arrowhead Pharmaceuticals Business Overview
7.8.3 Arrowhead Pharmaceuticals RNA Therapeutics Major Product Offerings
7.8.4 Arrowhead Pharmaceuticals RNA Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Arrowhead Pharmaceuticals Key News & Latest Developments
7.9 BioNTech
7.9.1 BioNTech Company Summary
7.9.2 BioNTech Business Overview
7.9.3 BioNTech RNA Therapeutics Major Product Offerings
7.9.4 BioNTech RNA Therapeutics Revenue in Global Market (2018-2023)
7.9.5 BioNTech Key News & Latest Developments
7.10 Orna Therapeutics
7.10.1 Orna Therapeutics Company Summary
7.10.2 Orna Therapeutics Business Overview
7.10.3 Orna Therapeutics RNA Therapeutics Major Product Offerings
7.10.4 Orna Therapeutics RNA Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Orna Therapeutics Key News & Latest Developments
7.11 CRISPR Therapeutics
7.11.1 CRISPR Therapeutics Company Summary
7.11.2 CRISPR Therapeutics Business Overview
7.11.3 CRISPR Therapeutics RNA Therapeutics Major Product Offerings
7.11.4 CRISPR Therapeutics RNA Therapeutics Revenue in Global Market (2018-2023)
7.11.5 CRISPR Therapeutics Key News & Latest Developments
7.12 Silence Therapeutics
7.12.1 Silence Therapeutics Company Summary
7.12.2 Silence Therapeutics Business Overview
7.12.3 Silence Therapeutics RNA Therapeutics Major Product Offerings
7.12.4 Silence Therapeutics RNA Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Silence Therapeutics Key News & Latest Developments
7.13 Astellas Pharma Inc.
7.13.1 Astellas Pharma Inc. Company Summary
7.13.2 Astellas Pharma Inc. Business Overview
7.13.3 Astellas Pharma Inc. RNA Therapeutics Major Product Offerings
7.13.4 Astellas Pharma Inc. RNA Therapeutics Revenue in Global Market (2018-2023)
7.13.5 Astellas Pharma Inc. Key News & Latest Developments
7.14 CureVac
7.14.1 CureVac Company Summary
7.14.2 CureVac Business Overview
7.14.3 CureVac RNA Therapeutics Major Product Offerings
7.14.4 CureVac RNA Therapeutics Revenue in Global Market (2018-2023)
7.14.5 CureVac Key News & Latest Developments
7.15 Sirnaomics
7.15.1 Sirnaomics Company Summary
7.15.2 Sirnaomics Business Overview
7.15.3 Sirnaomics RNA Therapeutics Major Product Offerings
7.15.4 Sirnaomics RNA Therapeutics Revenue in Global Market (2018-2023)
7.15.5 Sirnaomics Key News & Latest Developments
7.16 Arcturus Therapeutics
7.16.1 Arcturus Therapeutics Company Summary
7.16.2 Arcturus Therapeutics Business Overview
7.16.3 Arcturus Therapeutics RNA Therapeutics Major Product Offerings
7.16.4 Arcturus Therapeutics RNA Therapeutics Revenue in Global Market (2018-2023)
7.16.5 Arcturus Therapeutics Key News & Latest Developments
7.17 Arbutus Biopharma
7.17.1 Arbutus Biopharma Company Summary
7.17.2 Arbutus Biopharma Business Overview
7.17.3 Arbutus Biopharma RNA Therapeutics Major Product Offerings
7.17.4 Arbutus Biopharma RNA Therapeutics Revenue in Global Market (2018-2023)
7.17.5 Arbutus Biopharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
